Scenario Projections of COVID-19 Burden in the US, 2024-2025

In this decision analytical modeling study of COVID-19 burden in the US in 2024 to 2025, ensemble projections suggested that although vaccinating high-risk groups had substantial benefits in reducing disease burden, maintaining the vaccine recommendation for all individuals had the potential to save thousands more lives. Despite divergence of projections from observed disease trends in 2024 to 2025-possibly driven by variant emergence patterns and immune escape-averted COVID-19 burden due to vaccination was robust across immune escape scenarios, emphasizing the substantial benefit of broader vaccine availability for all individuals.

Authors

Institutions

Publication Details

Journal
JAMA Network Open
Published
2025-09-18
DOI
https://doi.org/10.1001/jamanetworkopen.2025.32469
Citations
3
Primary Topic
COVID-19 epidemiological studies
Type
article
Field-Weighted Citation Impact
4.10
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Scenario Projections of COVID-19 Burden in the US, 2024-2025

Jean‐Claude Thill, Ajitesh Srivastava, Clifton McKee, Anass Bouchnita et al.
3 citations
JAMA Network Open
COVID-19 epidemiological studies
4.10
article

Scenario Projections of COVID-19 Burden in the US, 2024-2025

Jean‐Claude Thill, Ajitesh Srivastava, Clifton McKee, Anass Bouchnita, Pete Riley, Sung-mok Jung, Przemyslaw Porebski, Madhav Marathe, Daniel Janies, Rajib Paul, Kaiming Bi, Samantha J. Bents, K.T. Sato, Katriona Shea, Justin Lessler, Sean M. Moore, Jessica T. Davis, Alessandro Vespignani, Sara L. Loo, Emily Howerton, Shraddha Ramdas Bandekar, James Turtle, Srinivasan Venkatramanan, Spencer J. Fox, Claire P. Smith, Joseph Chadi Lemaitre, Matteo Chinazzi, M. Ben-Nun, Jiangzhuo Chen, Majd Al Aawar, T. Alex Perkins, Bryan Lewis, Cécile Viboud, Michael C. Runge, Katie Yan, Alison L. Hill, Lucie Contamin, Clara Bay, Harry Hochheiser, Shaun Truelove, Lauren Ancel Meyers, Erica C. Carcelén, Shi Chen, Emily Przykucki
article en
3 citations

Abstract

In this decision analytical modeling study of COVID-19 burden in the US in 2024 to 2025, ensemble projections suggested that although vaccinating high-risk groups had substantial benefits in reducing disease burden, maintaining the vaccine recommendation for all individuals had the potential to save thousands more lives. Despite divergence of projections from observed disease trends in 2024 to 2025-possibly driven by variant emergence patterns and immune escape-averted COVID-19 burden due to vaccination was robust across immune escape scenarios, emphasizing the substantial benefit of broader vaccine availability for all individuals.

JAMA Network OpenVol. 8(9)
University of North Carolina at Charlotte (US), University of Notre Dame (US), University of North Carolina at Chapel Hill (US), University of Southern California (US), United States Geological Survey (US), Northeastern University (US), Pennsylvania State University (US), Johns Hopkins University (US), The University of Texas at El Paso (US), University of Georgia (US), University of Pittsburgh (US), Princeton University (US), Predictive Science (United States) (US), University of Virginia (US), The University of Texas at Austin (US), Fogarty International Center (US), The University of Texas Health Science Center at Houston (US)
Openalex Percentile: Top 6%
COVID-19 epidemiological studies
4.10
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.